Cargando…
CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective
BACKGROUND AND PURPOSE: Advances in the management of acute ischemic stroke and medical imaging are creating pressure to replace the rigid one-third middle cerebral artery (MCA) and non-contrast-enhanced CT (NCCT) Alberta Stroke Program Early CT Score (ASPECTS) thresholds used for the selection of p...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343752/ https://www.ncbi.nlm.nih.gov/pubmed/22566978 http://dx.doi.org/10.1159/000324324 |
_version_ | 1782231838863917056 |
---|---|
author | Sillanpaa, Niko Saarinen, Jukka T. Rusanen, Harri Hakomaki, Jari Lahteela, Arto Numminen, Heikki Elovaara, Irina Dastidar, Prasun Soimakallio, Seppo |
author_facet | Sillanpaa, Niko Saarinen, Jukka T. Rusanen, Harri Hakomaki, Jari Lahteela, Arto Numminen, Heikki Elovaara, Irina Dastidar, Prasun Soimakallio, Seppo |
author_sort | Sillanpaa, Niko |
collection | PubMed |
description | BACKGROUND AND PURPOSE: Advances in the management of acute ischemic stroke and medical imaging are creating pressure to replace the rigid one-third middle cerebral artery (MCA) and non-contrast-enhanced CT (NCCT) Alberta Stroke Program Early CT Score (ASPECTS) thresholds used for the selection of patients eligible for intravenous thrombolytic therapy. The identification of potentially salvageable ischemic brain tissue lies at the core of this issue. In this study, the role of CT perfusion ASPECTS in the detection of reversible ischemia was analyzed. MATERIALS AND METHODS: We retrospectively reviewed the clinical and imaging data of 92 consecutive patients who received intravenous thrombolytic therapy for acute (duration <3 h) ischemic stroke. Most of the patients underwent admission multimodal CT, and all patients had follow-up NCCT at 24 h. ASPECTS was assigned to all modalities and correlated with clinical and imaging parameters. Receiver-operating characteristic curve analysis was performed to determine optimal thresholds for different parameters to predict clinical outcome. RESULTS: A perfusion defect could be detected in 50% of the patients. ASPECTS correlated inversely with the clinical outcome in the following order: follow-up NCCT > cerebral blood volume (CBV) > mean transit time (MTT) > admission NCCT. The follow-up NCCT and the CBV displayed a statistically significant difference from the admission NCCT, while the MTT did not reach statistical significance. The threshold that best differentiated between good and bad clinical outcome on admission was CBV ASPECTS ≥7. In patients with CT perfusion ASPECTS mismatch, MTT and CBV ASPECTS essentially provided the lower and upper limits for the follow-up NCCT ASPECTS, thus defining the spectrum of possible outcomes. Furthermore, CT perfusion ASPECTS mismatch strongly correlated (r = 0.83) with the mismatch between the tissue at risk and the final infarct, i.e. the amount of salvaged tissue. This finding suggests that the CT perfusion ASPECTS mismatch adequately identifies the amount of potentially salvageable ischemic brain tissue. CONCLUSIONS: Parameters derived from the use of CT perfusion ASPECTS can detect reversible ischemia and are correlated with clinical outcome. |
format | Online Article Text |
id | pubmed-3343752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-33437522012-05-07 CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective Sillanpaa, Niko Saarinen, Jukka T. Rusanen, Harri Hakomaki, Jari Lahteela, Arto Numminen, Heikki Elovaara, Irina Dastidar, Prasun Soimakallio, Seppo Cerebrovasc Dis Extra Original Paper BACKGROUND AND PURPOSE: Advances in the management of acute ischemic stroke and medical imaging are creating pressure to replace the rigid one-third middle cerebral artery (MCA) and non-contrast-enhanced CT (NCCT) Alberta Stroke Program Early CT Score (ASPECTS) thresholds used for the selection of patients eligible for intravenous thrombolytic therapy. The identification of potentially salvageable ischemic brain tissue lies at the core of this issue. In this study, the role of CT perfusion ASPECTS in the detection of reversible ischemia was analyzed. MATERIALS AND METHODS: We retrospectively reviewed the clinical and imaging data of 92 consecutive patients who received intravenous thrombolytic therapy for acute (duration <3 h) ischemic stroke. Most of the patients underwent admission multimodal CT, and all patients had follow-up NCCT at 24 h. ASPECTS was assigned to all modalities and correlated with clinical and imaging parameters. Receiver-operating characteristic curve analysis was performed to determine optimal thresholds for different parameters to predict clinical outcome. RESULTS: A perfusion defect could be detected in 50% of the patients. ASPECTS correlated inversely with the clinical outcome in the following order: follow-up NCCT > cerebral blood volume (CBV) > mean transit time (MTT) > admission NCCT. The follow-up NCCT and the CBV displayed a statistically significant difference from the admission NCCT, while the MTT did not reach statistical significance. The threshold that best differentiated between good and bad clinical outcome on admission was CBV ASPECTS ≥7. In patients with CT perfusion ASPECTS mismatch, MTT and CBV ASPECTS essentially provided the lower and upper limits for the follow-up NCCT ASPECTS, thus defining the spectrum of possible outcomes. Furthermore, CT perfusion ASPECTS mismatch strongly correlated (r = 0.83) with the mismatch between the tissue at risk and the final infarct, i.e. the amount of salvaged tissue. This finding suggests that the CT perfusion ASPECTS mismatch adequately identifies the amount of potentially salvageable ischemic brain tissue. CONCLUSIONS: Parameters derived from the use of CT perfusion ASPECTS can detect reversible ischemia and are correlated with clinical outcome. S. Karger AG 2011-02-17 /pmc/articles/PMC3343752/ /pubmed/22566978 http://dx.doi.org/10.1159/000324324 Text en Copyright © 2011 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions. |
spellingShingle | Original Paper Sillanpaa, Niko Saarinen, Jukka T. Rusanen, Harri Hakomaki, Jari Lahteela, Arto Numminen, Heikki Elovaara, Irina Dastidar, Prasun Soimakallio, Seppo CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective |
title | CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective |
title_full | CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective |
title_fullStr | CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective |
title_full_unstemmed | CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective |
title_short | CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective |
title_sort | ct perfusion aspects in the evaluation of acute ischemic stroke: thrombolytic therapy perspective |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343752/ https://www.ncbi.nlm.nih.gov/pubmed/22566978 http://dx.doi.org/10.1159/000324324 |
work_keys_str_mv | AT sillanpaaniko ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective AT saarinenjukkat ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective AT rusanenharri ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective AT hakomakijari ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective AT lahteelaarto ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective AT numminenheikki ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective AT elovaarairina ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective AT dastidarprasun ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective AT soimakallioseppo ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective |